Related references
Note: Only part of the references are listed.Antibodies to Apolipoprotein A-I, High-Density Lipoprotein, and C-Reactive Protein Are Associated With Disease Activity in Patients With Systemic Lupus Erythematosus
Sean G. O'Neill et al.
ARTHRITIS AND RHEUMATISM (2010)
The Protective Effect of Antimalarial Drugs on Thrombovascular Events in Systemic Lupus Erythematosus
Hyejung Jung et al.
ARTHRITIS AND RHEUMATISM (2010)
Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus
Harmony R. Reynolds et al.
ATHEROSCLEROSIS (2010)
Regulation of autoreactive B cell responses to endogenous TLR ligands
Ana Maria Avalos et al.
AUTOIMMUNITY (2010)
Dysfunctional, pro-inflammatory HDL directly upregulates monocyte PDGFRβ, chemotaxis and TNFα production
Brian J. Skaggs et al.
CLINICAL IMMUNOLOGY (2010)
Atypical cardiac manifestation of hypereosinophilic syndrome and reversible cardiotoxicity to imatinib
Ana Garcia-Alvarez et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
B cell depletion reduces the development of atherosclerosis in mice
Hafid Ait-Oufella et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies
Armin Wolf et al.
LEUKEMIA RESEARCH (2010)
Atherosclerosis in CKD: differences from the general population
Tilman B. Drueeke et al.
NATURE REVIEWS NEPHROLOGY (2010)
The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis
Lee Ann Campbell et al.
MICROBES AND INFECTION (2010)
Long-term improvement of lipid profile in patients with refractory systemic lupus erythematosus treated with B-cell depletion therapy: a retrospective observational study
Jose M. Pego-Reigosa et al.
RHEUMATOLOGY (2010)
Osteoporosis and Cardiovascular Disease Care in Systemic Lupus Erythematosus According to New Quality Indicators
Kristina L. Demas et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis
Jennifer M. P. Woo et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort
R. Kaiser et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Effect of Fluvastatin on Cardiac Outcomes in Kidney Transplant Patients With Systemic Lupus Erythematosus A Randomized Placebo-Controlled Study
Gudrun E. Norby et al.
ARTHRITIS AND RHEUMATISM (2009)
A Quality Indicator Set for Systemic Lupus Erythematosus
Jinoos Yazdany et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Dysfunctional Proinflammatory High-Density Lipoproteins Confer Increased Risk of Atherosclerosis in Women With Systemic Lupus Erythematosus
Maureen McMahon et al.
ARTHRITIS AND RHEUMATISM (2009)
Premature Atherosclerosis in Pediatric Systemic Lupus Erythematosus
Laura E. Schanberg et al.
ARTHRITIS AND RHEUMATISM (2009)
Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis
C. P. Chung et al.
LUPUS (2009)
Adipokines as novel biomarkers in paediatric systemic lupus erythematosus
Marjon Al et al.
RHEUMATOLOGY (2009)
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study
Johanna Gustafsson et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Accumulation of coronary artery disease risk factors actors over three years:: Data from an international inception cohort
M. B. Urowitz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
The role of innate immunity in the induction of autoimmunity
David S. Pisetsky
AUTOIMMUNITY REVIEWS (2008)
Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis
Christina Charles-Schoeman et al.
CLINICAL IMMUNOLOGY (2008)
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
LeAnne T. Bloedon et al.
JOURNAL OF LIPID RESEARCH (2008)
Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus -: results from LUMINA (LIX):: a multiethnic US cohort
S. Duran-Barragan et al.
RHEUMATOLOGY (2008)
Serum leptin in systemic lupus erythematosus
M. Wislowska et al.
RHEUMATOLOGY INTERNATIONAL (2008)
Practical management of toxicities associated with tyrosine kinase inhibitors in chronic myeloid leukemia
Alfonso Quintas-Cardama et al.
CLINICAL LYMPHOMA & MYELOMA (2008)
Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus
Pui Y. Lee et al.
ARTHRITIS AND RHEUMATISM (2007)
Inteirferon-α promotes abnormal vasculogenesis in lupus:: a potential pathway for premature atherosclerosis
Michael F. Denny et al.
BLOOD (2007)
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus
Mary J. Roman et al.
ARTHRITIS AND RHEUMATISM (2007)
Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial
G. A. Ferreira et al.
RHEUMATOLOGY (2007)
Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus:: Data from LUMINA, a multiethnic US cohort (LUMINA L)
Graciela S. Alarcon et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Effects of simvastatin on human T cells in vivo
Pierre Cherfan et al.
ATHEROSCLEROSIS (2007)
Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis
Yoshisuke Haruna et al.
ARTHRITIS AND RHEUMATISM (2007)
Innate immunity modulates adipokines in humans
Paul D. Anderson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Cardiotoxicity of imatinib mesylate: an extremely rare phenomenon or a major side effect?
Joerg H. W. Distler et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups
A. Mak et al.
LUPUS (2007)
Leptin and atherosclerosis
Jerzy Beltowski
ATHEROSCLEROSIS (2006)
Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis
M. Otero et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis a murine lupus model
Tamar Aprahamian et al.
JOURNAL OF IMMUNOLOGY (2006)
Towards a pro-inflammatory and immunomodulatory emerging role of leptin
M. Otero et al.
RHEUMATOLOGY (2006)
Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis
Maureen McMahon et al.
ARTHRITIS AND RHEUMATISM (2006)
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Risto Kerkela et al.
NATURE MEDICINE (2006)
Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus
Joan M. Von Feldt et al.
ARTHRITIS AND RHEUMATISM (2006)
Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway
F Dong et al.
HYPERTENSION (2006)
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
G. Ruiz-Irastorza et al.
LUPUS (2006)
'Not only ... but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus
IN Bruce
RHEUMATOLOGY (2005)
Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus
KH Costenbader et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Cytokines and cardiovascular disease
VC Mehra et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
An oral ApoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice
M Navab et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Recent National Cholesterol Education Program Adult Treatment Panel III update: Adjustments and options
NJ Stone et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis
AD Hauer et al.
CIRCULATION (2005)
Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease
S Tsimikas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice
M Navab et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data
PRJ Ames et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis
PH Dessein et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Association of biological markers of activity of systemic lupus erythematosus with levels of anti-oxidized low-density lipoprotein antibodies
JM Gómez-Zumaquero et al.
RHEUMATOLOGY (2004)
Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study
A Ponthieux et al.
ATHEROSCLEROSIS (2004)
Endothelial cell activation by antiphospholipid antibodies
PL Meroni et al.
CLINICAL IMMUNOLOGY (2004)
Systemic lupus erythematosus - An independent risk factor for endothelial dysfunction in women
M El-Magadmi et al.
CIRCULATION (2004)
Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease
N Vuilleumier et al.
JOURNAL OF AUTOIMMUNITY (2004)
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
SM Grundy et al.
CIRCULATION (2004)
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) -: XXIII.: Baseline predictors of vascular events
SMA Toloza et al.
ARTHRITIS AND RHEUMATISM (2004)
Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus
R Bessant et al.
RHEUMATOLOGY (2004)
Circulating leptin is associated with oxidized LDL in postmenopausal women
E Porreca et al.
ATHEROSCLEROSIS (2004)
Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis
S Kang et al.
ATHEROSCLEROSIS (2004)
The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins lupus cohort
M Petri
THROMBOSIS RESEARCH (2004)
Oral D-4F causes formation of pre-β high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice
M Navab et al.
CIRCULATION (2004)
Inhibition of tumor necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout mice
L Branén et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Prevention of cardiovascular disease in systemic lupus erythematosus - proposed guidelines for risk factor management
J Wajed et al.
RHEUMATOLOGY (2004)
Comparison of risk factors for vascular disease in the carotid artery and systemic lupus aorta in women with erythematosus
F Selzer et al.
ARTHRITIS AND RHEUMATISM (2004)
Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with β2-glycoprotein I
J George et al.
CARDIOVASCULAR RESEARCH (2004)
Antiinflammatory properties of HDL
PJ Barter et al.
CIRCULATION RESEARCH (2004)
Increased Th1 activity in patients with coronary artery disease
JL Fernandes et al.
CYTOKINE (2004)
High-density lipoproteins neutralize C-reactive protein proinflammatory activity
C Wadham et al.
CIRCULATION (2004)
Premature coronary-artery atherosclerosis in systemic lupus erythematosus
Y Asanuma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus
MJ Roman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Inhibition of hydroxymethylglutaryl-coenzyme A reductase reduces Th1 development and promotes Th2 development
R Hakamada-Taguchi et al.
CIRCULATION RESEARCH (2003)
Risk factors for coronary heart disease in women with systemic lupus erythematosus -: The Toronto Risk Factor Study
IN Bruce et al.
ARTHRITIS AND RHEUMATISM (2003)
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus
A Doria et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Adhesion molecules and atherosclerosis
S Blankenberg et al.
ATHEROSCLEROSIS (2003)
Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody
D Nicolo et al.
ARTHRITIS AND RHEUMATISM (2003)
IL-6, TNF-α and atherosclerosis risk indicators in a healthy family population:: the STANISLAS cohort
N Haddy et al.
ATHEROSCLEROSIS (2003)
Factors associated with coronary artery calcification in young female patients with SLE
K Manger et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Antiphospholipid antibodies as a risk factor for atherosclerotic events in renal transplant recipients
D Ducloux et al.
KIDNEY INTERNATIONAL (2003)
Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo
YZ Zhang et al.
CIRCULATION (2003)
Hyperlipidemia and thrombotic complications in patients with membranous nephropathy
TL Nickolas et al.
SEMINARS IN NEPHROLOGY (2003)
Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome
JD Alves et al.
RHEUMATOLOGY (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway
AT Remaley et al.
JOURNAL OF LIPID RESEARCH (2003)
Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin
O Aktas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells
YI Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Atorvastatin reduces plasma MCP-1 in patients with acute coronary syndrome
ZM Xu et al.
CLINICA CHIMICA ACTA (2003)
Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study
A Theodoridou et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Statin inhibits interferon-γ-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells
HK Chung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2002)
Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells
U Schönbeck et al.
CIRCULATION (2002)
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
S Youssef et al.
NATURE (2002)
Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients
TMK Refai et al.
CLINICAL RHEUMATOLOGY (2002)
B-Lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice
AS Major et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36
EA Podrez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions
EA Podrez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Statins as immunomodulators -: Comparison with interferon-β1b in MS
O Neuhaus et al.
NEUROLOGY (2002)
Serum leptin levels in women with systemic lupus erythematosus
A Garcia-Gonzalez et al.
RHEUMATOLOGY INTERNATIONAL (2002)
IFN-γ deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice
SC Whitman et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2002)
Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells
PJ Barter et al.
CURRENT OPINION IN LIPIDOLOGY (2002)
Immune mechanisms in atherosclerosis
GK Hansson
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease - Effects of an early invasive or noninvasive strategy
E Lindmark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Risk factors for cardiovascular disease in systemic lupus erythematosus
E Svenungsson et al.
CIRCULATION (2001)
High-sensitivity C-reactive protein - Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
PM Ridker
CIRCULATION (2001)
Anti-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome
G Hayem et al.
LUPUS (2001)
Statins as a newly recognized type of immunomodulator
B Kwak et al.
NATURE MEDICINE (2000)
Interferon-γ induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells -: Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines
H Peilot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort
M Petri
LUPUS (2000)
Share Paper
